Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)
Conditions: Tuberculosis, Multidrug-Resistant; Extensively Drug-Resistant Tuberculosis; Tuberculosis, PulmonaryInterventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine; Drug: Locally accepted standard of care which is consistent with the WHO recommendations for the treatment of M/XDR-TB.Sponsors: Medecins Sans Frontieres; London School of Hygiene and Tropical Medicine; Global Alliance for TB Drug Development; University College, London; Ministry of Health, Swaziland; Drugs for Neglected Diseases; ...
Source: ClinicalTrials.gov - October 15, 2015 Category: Research Source Type: clinical trials
